17 datasets found
  1. Sexually transmitted infections (STIs): annual data

    • gov.uk
    Updated Jun 10, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    UK Health Security Agency (2025). Sexually transmitted infections (STIs): annual data [Dataset]. https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables
    Explore at:
    Dataset updated
    Jun 10, 2025
    Dataset provided by
    GOV.UKhttp://gov.uk/
    Authors
    UK Health Security Agency
    Description

    The UK Health Security Agency (UKHSA) collects data on all sexually transmitted infection (STI) diagnoses made at sexual health services in England. This page includes information on trends in STI diagnoses, as well as the numbers and rates of diagnoses by demographic characteristics and UKHSA public health region.

    View the pre-release access lists for these statistics.

    Previous reports, data tables, slide sets, infographics, and pre-release access lists are available online:

    The STI quarterly surveillance reports of provisional data for diagnoses of syphilis, gonorrhoea and ceftriaxone-resistant gonorrhoea in England are also available online.

    Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the https://code.statisticsauthority.gov.uk/" class="govuk-link">Code of Practice for Statistics that all producers of Official Statistics should adhere to.

  2. U.S. high school students who were tested for STDs in the past year, 2023,...

    • statista.com
    Updated Nov 15, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2024). U.S. high school students who were tested for STDs in the past year, 2023, by race [Dataset]. https://www.statista.com/statistics/1384704/share-high-school-students-tested-for-stds-by-race-ethnicity/
    Explore at:
    Dataset updated
    Nov 15, 2024
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    2023
    Area covered
    United States
    Description

    In 2023, only six percent of high school students in the United States reported being tested for sexually transmitted diseases (STDs) in the past year. This graph shows the percentage of high school students in the United States who were tested for STDs in the past year as of 2023, by race/ethnicity.

  3. U.S. high school students who were tested for STDs in the past year 2019-23,...

    • statista.com
    Updated Jul 18, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). U.S. high school students who were tested for STDs in the past year 2019-23, by race [Dataset]. https://www.statista.com/statistics/1384716/share-high-school-students-tested-for-stds-by-race-ethnicity-timeline/
    Explore at:
    Dataset updated
    Jul 18, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    In 2023, only around **** percent of white high school students in the United States reported being tested for sexually transmitted diseases (STDs) in the past year. This graph shows the percentage of high school students in the United States who were tested for STDs in the past year in 2019, 2021, and 2023, by race/ethnicity.

  4. Public Health Statistics - Gonorrhea cases for females aged 15-44 in...

    • healthdata.gov
    • data.cityofchicago.org
    • +2more
    application/rdfxml +5
    Updated Apr 8, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    data.cityofchicago.org (2025). Public Health Statistics - Gonorrhea cases for females aged 15-44 in Chicago, by year, 2000-2014 - Historical [Dataset]. https://healthdata.gov/dataset/Public-Health-Statistics-Gonorrhea-cases-for-femal/d2dx-rnbb
    Explore at:
    csv, application/rssxml, json, application/rdfxml, xml, tsvAvailable download formats
    Dataset updated
    Apr 8, 2025
    Dataset provided by
    data.cityofchicago.org
    Area covered
    Chicago
    Description

    Note: This dataset is historical only and STI surveillance data do not change once finalized. For the most recent STI data, please refer to the CDPH Health Atlas (chicagohealthatlas.org), the annual HIV/STI surveillance report, and the Getting to Zero Illinois HIV Dashboard (gtzillinois.hiv).

    The annual number of newly reported, laboratory-confirmed cases of gonorrhea (Neisseria gonorrhoeae) among females aged 15-44 years and annual gonorrhea incidence rate (cases per 100,000 females aged 15-44 years) with corresponding 95% confidence intervals by Chicago community area, for years 2000 – 2014. See the full description by clicking on the maroon "About" button on the right-hand side of the screen, and click on the PDF under "Attachments".

  5. Sexually Transmitted Diseases (STD) Treatment Market Analysis, Size, and...

    • technavio.com
    pdf
    Updated Jul 17, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Technavio (2025). Sexually Transmitted Diseases (STD) Treatment Market Analysis, Size, and Forecast 2025-2029: North America (US and Canada), Europe (France, Germany, Italy, Spain, and UK), APAC (China, India, and Japan), and Rest of World (ROW) [Dataset]. https://www.technavio.com/report/sexually-transmitted-diseases-std-treatment-market-industry-analysis
    Explore at:
    pdfAvailable download formats
    Dataset updated
    Jul 17, 2025
    Dataset provided by
    TechNavio
    Authors
    Technavio
    Time period covered
    2025 - 2029
    Area covered
    United Kingdom, Canada, United States
    Description

    Snapshot img

    Sexually Transmitted Diseases Treatment Market Size 2025-2029

    The sexually transmitted diseases (STD) treatment market size is forecast to increase by USD 24.21 billion at a CAGR of 7% between 2024 and 2029.

    The market is experiencing significant growth due to the increasing prevalence of these diseases worldwide. The rising number of cases, driven by factors such as increasing sexual activity, lack of awareness, and social stigma, presents a substantial opportunity for market participants. Moreover, advances in rapid diagnosis techniques are enabling earlier detection and treatment, improving patient outcomes and reducing the spread of STDs. However, challenges persist in the form of limited healthcare services in developing regions, where access to diagnosis and treatment remains inadequate.
    This disparity in healthcare infrastructure poses a significant obstacle to market expansion and calls for innovative solutions, such as telemedicine and mobile clinics, to reach underserved populations. Companies seeking to capitalize on market opportunities must navigate these challenges effectively, focusing on developing affordable, accessible, and effective diagnostic and treatment solutions to address the unmet needs in the global market.
    

    What will be the Size of the Sexually Transmitted Diseases (STD) Treatment Market during the forecast period?

    Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
    Request Free Sample

    The market for sexually transmitted disease (STD) treatment continues to evolve, driven by the dynamic nature of infection transmission dynamics and the ongoing research in various sectors. Sexual health awareness campaigns and infection prevention measures have led to increased diagnostic test accuracy, enabling early identification and treatment of STDs. Treatment efficacy metrics and cost-effectiveness studies are crucial in addressing health disparities and optimizing clinical practice recommendations. For instance, a longitudinal study revealed a 25% decrease in chlamydia infections among women following the implementation of partner notification programs and evidence-based guidelines.

    The industry anticipates a 10% annual growth in the next decade, fueled by advancements in pathogen identification, drug resistance mechanisms, and clinical trial results. Furthermore, healthcare provider training, antiretroviral therapy, and contact tracing strategies are essential components of disease surveillance systems and disease prevention efforts. Data analysis techniques, vaccine efficacy studies, and behavioral interventions also contribute to the ongoing research and development in the field. According to the World Health Organization, approximately one million new STD infections occur daily worldwide.

    How is this Sexually Transmitted Diseases (STD) Treatment Industry segmented?

    The sexually transmitted diseases (STD) treatment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

    Type
    
      Viral infections
      Bacterial infections
      Others
    
    
    Route Of Administration
    
      Oral
      Topical
      Injectable
    
    
    End-user
    
      Hospital and clinics
      Diagnostic centers
      Individuals
    
    
    Geography
    
      North America
    
        US
        Canada
    
    
      Europe
    
        France
        Germany
        Italy
        Spain
        UK
    
    
      APAC
    
        China
        India
        Japan
    
    
      Rest of World (ROW)
    

    By Type Insights

    The Viral infections segment is estimated to witness significant growth during the forecast period. The market is experiencing significant growth due to the rising prevalence of viral infections. Notable viral STDs include human papillomavirus (HPV), herpes simplex virus (HSV), hepatitis B virus (HBV), and Human Immunodeficiency Virus (HIV). Among these, HPV is the most common globally, with over 40 distinct types capable of infecting the genital tract. In the US, approximately 42-45% of adults aged 18-59 years were affected by genital HPV infection during 2023 and 2024, according to the Centers for Disease Control and Prevention (CDC). HPV can lead to health issues such as cervical cancer and genital warts. Public health interventions, such as vaccinations and screening programs, are crucial in mitigating the impact of these diseases. The human papillomavirus vaccine and hepatitis B vaccination are essential preventive measures.

    Chlamydia treatment guidelines, syphilis serological testing, and clinical trial methodologies contribute to the development of effective treatments. Epidemiological surveillance data informs healthcare resource allocation, while STD diagnostic testing, HIV pre- and post-exposure prophylaxis, pelvic inflammatory disease treatment, and drug interaction profiles ensure proper patien

  6. U.S. high school students who were tested for STDs in the past year 2019-23...

    • statista.com
    Updated Nov 15, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2024). U.S. high school students who were tested for STDs in the past year 2019-23 by gender [Dataset]. https://www.statista.com/statistics/1384746/share-high-school-students-tested-for-stds-by-gender-timeline/
    Explore at:
    Dataset updated
    Nov 15, 2024
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    In 2023, only around four percent of male high school students in the United States reported being tested for sexually transmitted diseases (STDs) in the past year. This graph shows the percentage of high school students in the United States who were tested for STDs in the past year in 2019, 2021, and 2023, by gender.

  7. d

    Public Health Statistics - Chlamydia cases among males aged 15-44 in...

    • catalog.data.gov
    • data.cityofchicago.org
    • +1more
    Updated Dec 2, 2023
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    data.cityofchicago.org (2023). Public Health Statistics - Chlamydia cases among males aged 15-44 in Chicago, by year, 2000-2014 - Historical [Dataset]. https://catalog.data.gov/dataset/public-health-statistics-chlamydia-cases-among-males-aged-15-44-in-chicago-by-year-2000-20
    Explore at:
    Dataset updated
    Dec 2, 2023
    Dataset provided by
    data.cityofchicago.org
    Area covered
    Chicago
    Description

    Note: This dataset is historical only and STI surveillance data do not change once finalized. For the most recent STI data, please refer to the CDPH Health Atlas (chicagohealthatlas.org), the annual HIV/STI surveillance report, and the Getting to Zero Illinois HIV Dashboard (gtzillinois.hiv). The annual number of newly reported, laboratory-confirmed cases of chlamydia (Chlamydia trachomatis) among males aged 15-44 years and annual chlamydia incidence rate (cases per 100,000 males aged 15-44 years) with corresponding 95% confidence intervals by Chicago community area, for years 2000 – 2014. See the full description by clicking on the maroon "About" button on the right-hand side of the screen, and click on the PDF under "Attachments".

  8. Sexually Transmitted Disease (STD) Testing Market Analysis, Size, and...

    • technavio.com
    pdf
    Updated Sep 6, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Technavio (2024). Sexually Transmitted Disease (STD) Testing Market Analysis, Size, and Forecast 2024-2028: North America (US and Canada), Europe (France, Germany, Italy, and UK), Middle East and Africa (Egypt, KSA, Oman, and UAE), APAC (China, India, and Japan), South America (Argentina and Brazil), and Rest of World (ROW) [Dataset]. https://www.technavio.com/report/sexually-transmitted-disease-std-testing-market-industry-analysis
    Explore at:
    pdfAvailable download formats
    Dataset updated
    Sep 6, 2024
    Dataset provided by
    TechNavio
    Authors
    Technavio
    Time period covered
    2024 - 2028
    Area covered
    Saudi Arabia, United Kingdom, Canada, United States
    Description

    Snapshot img

    Sexually Transmitted Disease Testing Market Size 2024-2028

    The sexually transmitted disease (STD) testing market size is forecast to increase by USD 32.37 billion, at a CAGR of 5.6% between 2023 and 2028.

    The market is experiencing significant growth due to the increasing prevalence of these diseases worldwide. The rising awareness about the importance of early detection and treatment of STDs, coupled with advances in rapid diagnostic technologies, is driving market expansion. However, challenges persist, particularly in developing regions where limited healthcare services and inadequate resources hinder widespread testing and effective disease management. These regions require targeted interventions and collaborative efforts from governments, NGOs, and private sector players to improve access to affordable and accurate STD testing services.
    Companies in the market can capitalize on this opportunity by focusing on developing innovative, cost-effective testing solutions and expanding their reach into underserved markets. The market is also witnessing the introduction of point-of-care testing devices, home-based testing kits, telemedicine solutions, and immunoassay technologies, which are expected to increase the accessibility and affordability of STD testing. Additionally, partnerships with healthcare providers and organizations can help build trust and credibility, ultimately contributing to long-term market success.
    

    What will be the Size of the Sexually Transmitted Disease (STD) Testing Market during the forecast period?

    Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
    Request Free Sample

    The STD testing market continues to evolve, driven by advancements in technology and the ongoing need for effective disease prevention and diagnosis. FDA clearance of new testing methods, such as molecular tests and rapid antigen tests, expands the diagnostic landscape. False negative rates remain a concern, necessitating continuous quality control and test validation efforts. Ethical considerations, including patient education and informed consent, are paramount in ensuring accessible testing for all. Disease prevention and epidemiological research are key applications, with contact tracing and point-of-care testing playing crucial roles in public health initiatives. Clinical trials and diagnostic laboratories are integral components of the testing process, while serological tests and next-generation testing methods offer new possibilities in disease detection.

    Drug discovery and personalized medicine are gaining traction, with machine learning and predictive diagnostics aiding in more accurate test results interpretation. Testing affordability and reimbursement models are essential considerations, as is the integration of digital health platforms and automated testing. Regulatory approvals, including CE marking, continue to shape market dynamics. Testing accessibility is a priority, with home testing kits, travel testing, and workplace testing gaining popularity. Saliva and urine testing methods offer convenience and ease of use. Test turnaround time, pricing strategies, and treatment options are essential factors influencing market trends. Disease surveillance and biohazard waste management are critical aspects of the testing process.

    The ongoing unfolding of market activities underscores the importance of continuous innovation and adaptation to meet the evolving needs of the healthcare industry.

    How is this Sexually Transmitted Disease (STD) Testing Industry segmented?

    The sexually transmitted disease (STD) testing industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

    Product
    
      Laboratory testing device
      POC testing device
    
    
    Disease Type
    
      Chlamydia
      Gonorrhea
      Syphilis
      Trichomoniasis
      Others
    
    
    End-User
    
      Hospitals & Clinics
      Diagnostic Laboratories
      Home Care Settings
      Research & Academic Institutes
    
    
    Geography
    
      North America
    
        US
        Canada
    
    
      Europe
    
        France
        Germany
        Italy
        UK
    
    
      Middle East and Africa
    
        Egypt
        KSA
        Oman
        UAE
    
    
      APAC
    
        China
        India
        Japan
    
    
      South America
    
        Argentina
        Brazil
    
    
      Rest of World (ROW)
    

    By Product Insights

    The laboratory testing device segment is estimated to witness significant growth during the forecast period.

    The market is experiencing significant growth due to the rising prevalence of STDs, driven by unprotected sex and inadequate sex education. This market encompasses various diagnostic methods, including PCR testing, clinical development, test data management, blood testing, test reporting, machine learning, predictive diagnostics, rapid antig

  9. M

    Sexually Transmitted Disease Market Poised to Hit USD 171 Bn by 2032

    • media.market.us
    Updated Jan 9, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Market.us Media (2025). Sexually Transmitted Disease Market Poised to Hit USD 171 Bn by 2032 [Dataset]. https://media.market.us/sexually-transmitted-disease-market-news/
    Explore at:
    Dataset updated
    Jan 9, 2025
    Dataset authored and provided by
    Market.us Media
    License

    https://media.market.us/privacy-policyhttps://media.market.us/privacy-policy

    Time period covered
    2022 - 2032
    Description

    Introduction

    The Sexually Transmitted Disease (STD) Market Size is projected to grow from USD 95 billion in 2022 to USD 171 billion by 2032, at a compound annual growth rate of 6.17%. This expansion is driven by the urgent need for enhanced public health strategies and comprehensive sexual health education, particularly among young and marginalized groups.

    Educational initiatives are critical in addressing rising STD rates. Programs like the Real Education for Healthy Youth Act provide essential information on sexual health, promoting the use of contraceptives, recognition of symptoms, and the significance of regular testing. Such education efforts are fundamental in reducing STD incidence.

    Technological advancements in diagnostics and treatment also play a crucial role in managing STDs. The development of rapid and at-home testing kits offers privacy and convenience, encouraging more people to undergo regular screenings. Furthermore, progress in treatments and vaccine research, especially for HPV, contributes significantly to disease control and prevention.

    Effective public policies and accessible healthcare are essential for reducing STD-related stigma and barriers to treatment. Policies that ensure confidential care and expand funding for STI clinics can greatly improve access to necessary services. Additionally, community strategies like expedited partner therapy, which treats partners without prior testing, are vital in preventing the spread of infections.

    Collectively, these factors underscore the importance of a holistic approach involving education, advanced medical solutions, supportive policies, and community engagement to tackle the challenges within the STD sector effectively.

    https://market.us/wp-content/uploads/2023/02/Sexually-Transmitted-Disease-Market-Value.jpg" alt="Sexually Transmitted Disease Market Value">

  10. Syphilis rates in the United States in 2023, by race/ethnicity and gender

    • statista.com
    Updated Feb 17, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Syphilis rates in the United States in 2023, by race/ethnicity and gender [Dataset]. https://www.statista.com/statistics/622887/syphilis-rate-in-the-us-by-ethnicity-and-gender/
    Explore at:
    Dataset updated
    Feb 17, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    2023
    Area covered
    United States
    Description

    Rates of syphilis in the United States are higher among men than women. This is true for every race and ethnicity, although the difference varies greatly. For example, among the Black population, there were around 62.3 cases of syphilis among men per 100,000 population in 2023 and only 18.8 cases per 100,000 population among women. On the other hand, rates of syphilis among American Indians/Alaska Natives were similarly high for both men and women with rates of 63.6 and 52.9 per 100,000 population, respectively. What is syphilis? Syphilis is a common and treatable sexually transmitted disease (STD). Anyone who is sexually active can contract syphilis, however men who have sex with only men accounted for slightly more cases than other groups in 2022. There are four stages of syphilis, and each stage has different signs and symptoms. The stages are primary, secondary, latent, and tertiary. Syphilis can be cured with antibiotics. How many people get syphilis each year? In 2022, there were around 207,255 cases of syphilis in the United States. This was the highest number of cases recorded since the 1950s. In comparison, in the year 2000, there were only around 31,618 cases. Like chlamydia and gonorrhea, rates of syphilis in the United States have increased over the past couple decades reaching 62 per 100,000 population in 2022. However, this rate is still far below the rate of 146 cases per 100,000 population recorded in 1950. Rates of syphilis in the U.S. are highest among people in their twenties and early thirties.

  11. a

    ‘Public health statistics - Gonorrhea cases for males aged 15-44 in Chicago,...

    • analyst-2.ai
    Updated Feb 13, 2022
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Analyst-2 (analyst-2.ai) / Inspirient GmbH (inspirient.com) (2022). ‘Public health statistics - Gonorrhea cases for males aged 15-44 in Chicago, by year, 2000-2014 - Historical’ analyzed by Analyst-2 [Dataset]. https://analyst-2.ai/analysis/data-gov-public-health-statistics-gonorrhea-cases-for-males-aged-15-44-in-chicago-by-year-2000-2014-historical-818c/0356b215/?iid=004-660&v=presentation
    Explore at:
    Dataset updated
    Feb 13, 2022
    Dataset authored and provided by
    Analyst-2 (analyst-2.ai) / Inspirient GmbH (inspirient.com)
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    Chicago
    Description

    Analysis of ‘Public health statistics - Gonorrhea cases for males aged 15-44 in Chicago, by year, 2000-2014 - Historical’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://catalog.data.gov/dataset/6e415e7c-321b-4a99-b4a7-b4ebed0de8c2 on 13 February 2022.

    --- Dataset description provided by original source is as follows ---

    Note: This dataset is historical only and STI surveillance data do not change once finalized. For the most recent STI data, please refer to the CDPH Health Atlas (chicagohealthatlas.org), the annual HIV/STI surveillance report, and the Getting to Zero Illinois HIV Dashboard (gtzillinois.hiv).

    The annual number of newly reported, laboratory-confirmed cases of gonorrhea (Neisseria gonorrhoeae) among males aged 15-44 years and annual gonorrhea incidence rate (cases per 100,000 males aged 15-44 years) with corresponding 95% confidence intervals by Chicago community area, for years 2000 – 2014. See the full description by clicking on the maroon "About" button on the right-hand side of the screen, and click on the PDF under "Attachments".

    --- Original source retains full ownership of the source dataset ---

  12. A

    ‘Public Health Statistics - Gonorrhea cases for females aged 15-44 in...

    • analyst-2.ai
    Updated Feb 13, 2022
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Analyst-2 (analyst-2.ai) / Inspirient GmbH (inspirient.com) (2022). ‘Public Health Statistics - Gonorrhea cases for females aged 15-44 in Chicago, by year, 2000-2014 - Historical’ analyzed by Analyst-2 [Dataset]. https://analyst-2.ai/analysis/data-gov-public-health-statistics-gonorrhea-cases-for-females-aged-15-44-in-chicago-by-year-2000-2014-historical-1566/95738894/?iid=004-672&v=presentation
    Explore at:
    Dataset updated
    Feb 13, 2022
    Dataset authored and provided by
    Analyst-2 (analyst-2.ai) / Inspirient GmbH (inspirient.com)
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    Chicago
    Description

    Analysis of ‘Public Health Statistics - Gonorrhea cases for females aged 15-44 in Chicago, by year, 2000-2014 - Historical’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://catalog.data.gov/dataset/cae7396d-0751-4590-b80a-fd6939c56398 on 13 February 2022.

    --- Dataset description provided by original source is as follows ---

    Note: This dataset is historical only and STI surveillance data do not change once finalized. For the most recent STI data, please refer to the CDPH Health Atlas (chicagohealthatlas.org), the annual HIV/STI surveillance report, and the Getting to Zero Illinois HIV Dashboard (gtzillinois.hiv).

    The annual number of newly reported, laboratory-confirmed cases of gonorrhea (Neisseria gonorrhoeae) among females aged 15-44 years and annual gonorrhea incidence rate (cases per 100,000 females aged 15-44 years) with corresponding 95% confidence intervals by Chicago community area, for years 2000 – 2014. See the full description by clicking on the maroon "About" button on the right-hand side of the screen, and click on the PDF under "Attachments".

    --- Original source retains full ownership of the source dataset ---

  13. A

    ‘Public Health Statistics - Chlamydia cases among males aged 15-44 in...

    • analyst-2.ai
    Updated Feb 13, 2022
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Analyst-2 (analyst-2.ai) / Inspirient GmbH (inspirient.com) (2022). ‘Public Health Statistics - Chlamydia cases among males aged 15-44 in Chicago, by year, 2000-2014 - Historical’ analyzed by Analyst-2 [Dataset]. https://analyst-2.ai/analysis/data-gov-public-health-statistics-chlamydia-cases-among-males-aged-15-44-in-chicago-by-year-2000-2014-historical-d368/8481fe81/?iid=004-941&v=presentation
    Explore at:
    Dataset updated
    Feb 13, 2022
    Dataset authored and provided by
    Analyst-2 (analyst-2.ai) / Inspirient GmbH (inspirient.com)
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    Chicago
    Description

    Analysis of ‘Public Health Statistics - Chlamydia cases among males aged 15-44 in Chicago, by year, 2000-2014 - Historical’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://catalog.data.gov/dataset/3322a4ce-e4ef-46a1-b007-a90be7c0bfe9 on 13 February 2022.

    --- Dataset description provided by original source is as follows ---

    Note: This dataset is historical only and STI surveillance data do not change once finalized. For the most recent STI data, please refer to the CDPH Health Atlas (chicagohealthatlas.org), the annual HIV/STI surveillance report, and the Getting to Zero Illinois HIV Dashboard (gtzillinois.hiv).

    The annual number of newly reported, laboratory-confirmed cases of chlamydia (Chlamydia trachomatis) among males aged 15-44 years and annual chlamydia incidence rate (cases per 100,000 males aged 15-44 years) with corresponding 95% confidence intervals by Chicago community area, for years 2000 – 2014. See the full description by clicking on the maroon "About" button on the right-hand side of the screen, and click on the PDF under "Attachments".

    --- Original source retains full ownership of the source dataset ---

  14. A

    ‘Public Health Statistics - Chlamydia cases among females aged 15-44 in...

    • analyst-2.ai
    Updated Feb 13, 2022
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Analyst-2 (analyst-2.ai) / Inspirient GmbH (inspirient.com) (2022). ‘Public Health Statistics - Chlamydia cases among females aged 15-44 in Chicago, by year, 2000-2014 - Historical’ analyzed by Analyst-2 [Dataset]. https://analyst-2.ai/analysis/data-gov-public-health-statistics-chlamydia-cases-among-females-aged-15-44-in-chicago-by-year-2000-2014-historical-e1ac/a8dc3fb0/?iid=005-069&v=presentation
    Explore at:
    Dataset updated
    Feb 13, 2022
    Dataset authored and provided by
    Analyst-2 (analyst-2.ai) / Inspirient GmbH (inspirient.com)
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    Chicago
    Description

    Analysis of ‘Public Health Statistics - Chlamydia cases among females aged 15-44 in Chicago, by year, 2000-2014 - Historical’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://catalog.data.gov/dataset/b63759f8-65a0-4798-b615-078764b90e8e on 13 February 2022.

    --- Dataset description provided by original source is as follows ---

    Note: This dataset is historical only and STI surveillance data do not change once finalized. For the most recent STI data, please refer to the CDPH Health Atlas (chicagohealthatlas.org), the annual HIV/STI surveillance report, and the Getting to Zero Illinois HIV Dashboard (gtzillinois.hiv).

    The annual number of newly reported, laboratory-confirmed cases of chlamydia (Chlamydia trachomatis) among females aged 15-44 years and annual chlamydia incidence rate (cases per 100,000 females aged 15-44 years) with corresponding 95% confidence intervals by Chicago community area, for years 2000 – 2014. See the full description by clicking on the maroon "About" button on the right-hand side of the screen, and click on the PDF under "Attachments".

    --- Original source retains full ownership of the source dataset ---

  15. T

    Sao Tome and Principe Dobra Data

    • tradingeconomics.com
    • ru.tradingeconomics.com
    • +13more
    csv, excel, json, xml
    Updated Jul 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Sao Tome and Principe Dobra Data [Dataset]. https://tradingeconomics.com/sao-tome-and-principe/currency
    Explore at:
    csv, json, xml, excelAvailable download formats
    Dataset updated
    Jul 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Sep 7, 1994 - Aug 22, 2025
    Area covered
    São Tomé and Príncipe
    Description

    The USD/STD exchange rate fell to 21.1060 on August 22, 2025, down 0.97% from the previous session. Over the past month, the Sao Tome and Principe Dobra has weakened 0.40%, but it's up by 5.14% over the last 12 months. Sao Tome and Principe Dobra - values, historical data, forecasts and news - updated on August of 2025.

  16. T

    Singapore Stock Market (STI) Data

    • tradingeconomics.com
    • id.tradingeconomics.com
    • +13more
    csv, excel, json, xml
    Updated Nov 21, 2014
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2014). Singapore Stock Market (STI) Data [Dataset]. https://tradingeconomics.com/singapore/stock-market
    Explore at:
    excel, xml, csv, jsonAvailable download formats
    Dataset updated
    Nov 21, 2014
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Dec 28, 1987 - Aug 22, 2025
    Area covered
    Singapore
    Description

    Singapore's main stock market index, the STI, rose to 4253 points on August 22, 2025, gaining 0.52% from the previous session. Over the past month, the index has climbed 0.51% and is up 25.53% compared to the same time last year, according to trading on a contract for difference (CFD) that tracks this benchmark index from Singapore. Singapore Stock Market (STI) - values, historical data, forecasts and news - updated on August of 2025.

  17. T

    STI - 주가

    • ko.tradingeconomics.com
    csv, excel, json, xml
    Updated Aug 22, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). STI - 주가 [Dataset]. https://ko.tradingeconomics.com/fssti:ind
    Explore at:
    xml, excel, json, csvAvailable download formats
    Dataset updated
    Aug 22, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Aug 24, 2025
    Area covered
    Singapore
    Description

    Prices for STI - 주가 including live quotes, historical charts and news. STI - 주가 was last updated by Trading Economics this August 24 of 2025.

  18. Not seeing a result you expected?
    Learn how you can add new datasets to our index.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
UK Health Security Agency (2025). Sexually transmitted infections (STIs): annual data [Dataset]. https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables
Organization logo

Sexually transmitted infections (STIs): annual data

Explore at:
279 scholarly articles cite this dataset (View in Google Scholar)
Dataset updated
Jun 10, 2025
Dataset provided by
GOV.UKhttp://gov.uk/
Authors
UK Health Security Agency
Description

The UK Health Security Agency (UKHSA) collects data on all sexually transmitted infection (STI) diagnoses made at sexual health services in England. This page includes information on trends in STI diagnoses, as well as the numbers and rates of diagnoses by demographic characteristics and UKHSA public health region.

View the pre-release access lists for these statistics.

Previous reports, data tables, slide sets, infographics, and pre-release access lists are available online:

The STI quarterly surveillance reports of provisional data for diagnoses of syphilis, gonorrhoea and ceftriaxone-resistant gonorrhoea in England are also available online.

Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the https://code.statisticsauthority.gov.uk/" class="govuk-link">Code of Practice for Statistics that all producers of Official Statistics should adhere to.

Search
Clear search
Close search
Google apps
Main menu